Literature DB >> 22830497

New cathepsin D inhibitor library utilizing hydroxyethyl isosteres with cyclic tertiary amines.

Rose M McConnell1, Kalyani Inapudi, Naveen Kadasala, Karthika Yarlagadda, Priya Velusamy, Matthew S McConnell, Adam Green, Carol Trana, Kelley Sayyar, James S McConnell.   

Abstract

The design and synthesis of hydroxyethylamine isosteres as inhibitors of cathepsin D based on SAR data have been accomplished. A library of 96 of these hydroxyethylamine isosteres are described and many have proven to be very potent inhibitors of human cathepsin D activity as measured using a fluorometric assay technique, via peptide substrate Ac-Glu-Glu(Edans)-Lys-Pro-Ile-Cys-Phe-Phe-Arg-Leu-Gly-Lys(Methyl Red)-Glu-NH(2). Compounds showing strongest inhibition of cathepsin D activity were those that contain a hydroxyethyl-N'-2- or N'-(4-chlorophenyl)piperazine moiety (IC(50) values range from 0.55 to 8.5 nM), with N'-(2-pyrimidyl)piperizine (IC(50) values range from 0.5 to 21.6 nM), with N-N'- L-piperazinocolinamide (IC(50) values range from 0.001 - 0.25 nM), or N-N'-L-piperazinocolin-N-methylamide (IC(50) values range from 0.015 - 7.3 nM).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22830497      PMCID: PMC3535272          DOI: 10.2174/1573406411208061146

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  40 in total

1.  Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution.

Authors:  Takuya Miura; Koushi Hidaka; Tsuyoshi Uemura; Keisuke Kashimoto; Yuto Hori; Yuko Kawasaki; Adam J Ruben; Ernesto Freire; Tooru Kimura; Yoshiaki Kiso
Journal:  Bioorg Med Chem Lett       Date:  2010-06-25       Impact factor: 2.823

2.  Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents.

Authors:  Deepak Gupta; Ravikiran S Yedidi; Sheeba Varghese; Ladislau C Kovari; Patrick M Woster
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

3.  Effectiveness of commercial inhibitors against subtype F HIV-1 protease.

Authors:  Sandra Krauchenco; Nadia H Martins; Mario Sanches; Igor Polikarpov
Journal:  J Enzyme Inhib Med Chem       Date:  2009-06       Impact factor: 5.051

4.  Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells.

Authors:  Peng Guo; Xue-Yuan Dong; Ke-Wen Zhao; Xiaodong Sun; Qunna Li; Jin-Tang Dong
Journal:  Int J Cancer       Date:  2010-01-01       Impact factor: 7.396

5.  Biomarkers for breast cancer: the search continues.

Authors:  Ricardo H Alvarez; Janet E Price
Journal:  Cancer Biol Ther       Date:  2010-01-10       Impact factor: 4.742

6.  Proteomic profiling of proteins associated with lymph node metastasis in colorectal cancer.

Authors:  Yiming Ma; Mei Zhao; Jialing Zhong; Lan Shi; Qing Luo; Jian Liu; Jia Wang; Xinghua Yuan; Changzhi Huang
Journal:  J Cell Biochem       Date:  2010-08-15       Impact factor: 4.429

7.  Discovery of potent BACE-1 inhibitors containing a new hydroxyethylene (HE) scaffold: exploration of P1' alkoxy residues and an aminoethylene (AE) central core.

Authors:  Catarina Björklund; Hans Adolfsson; Katarina Jansson; Jimmy Lindberg; Lotta Vrang; Anders Hallberg; Sa Rosenquist; Bertil Samuelsson
Journal:  Bioorg Med Chem       Date:  2010-01-11       Impact factor: 3.641

8.  Prosaposin down-modulation decreases metastatic prostate cancer cell adhesion, migration, and invasion.

Authors:  Siyi Hu; Nathalie Delorme; Zhenzhen Liu; Tao Liu; Cruz Velasco-Gonzalez; Jone Garai; Ashok Pullikuth; Shahriar Koochekpour
Journal:  Mol Cancer       Date:  2010-02-04       Impact factor: 27.401

9.  Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients.

Authors:  A Kulić; M Sirotković-Skerlev; S Jelisavac-Cosić; D Herceg; Z Kovac; D Vrbanec
Journal:  Med Oncol       Date:  2009-09-11       Impact factor: 3.064

10.  Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer.

Authors:  Manousos Makridakis; Sarantis Gagos; Andreas Petrolekas; Maria G Roubelakis; Vasiliki Bitsika; Konstantinos Stravodimos; Kitty Pavlakis; Nicholas P Anagnou; Jonathan Coleman; Antonia Vlahou
Journal:  Proteomics       Date:  2009-01       Impact factor: 3.984

View more
  2 in total

1.  Lysosomal protease cathepsin D; a new driver of apoptosis during acute kidney injury.

Authors:  Pasquale Cocchiaro; Christopher Fox; Nicholas W Tregidgo; Rachel Howarth; Katrina M Wood; Gerhard R Situmorang; Luigi M Pavone; Neil S Sheerin; Anna Moles
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

Review 2.  Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy.

Authors:  Valeria De Pasquale; Anna Moles; Luigi Michele Pavone
Journal:  Cells       Date:  2020-04-15       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.